Abstract
This study aimed to compare the outcomes associated with valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) with the redo bioprosthetic surgical AVR (SAVR). We utilized the data of the years 2012-2016 from the US National Inpatient Sample to identify patients who were hospitalized for
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
